Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03101566
Title Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

biliary tract cancer

Therapies

Cisplatin + Gemcitabine + Nivolumab

Ipilimumab + Nivolumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Atlanta Georgia 30322 United States Details
Northwestern University Chicago Illinois 60611 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
University of Washington Seattle Washington 98109 United States Details
University of Wisconsin Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field